Healthcare Finance News December 26, 2024
Jeff Lagasse

New AI startups are facing difficulty getting off the ground even as the industry leans hard into the technology.

Artificial intelligence is poised to become a major force in healthcare. The technology is developing at breakneck speed, and both payers and providers are examining the potential use cases, with one survey from November showing 73% of organizations plan on growing their financial commitments to the technology. But because AI is so new, there are still some knots left to be untangled.

One of the biggest knots is reimbursement – specifically, the reimbursement of new AI-driven devices and processes. Reimbursement is paramount to improving access to advanced tools, but even for FDA-cleared devices, the path to reimbursement for these technologies is...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Technology
Samsung’s C-Lab to Showcase AI and Health Projects at CES
DeepSeek-V3, ultra-large open-source AI, outperforms Llama and Qwen on launch
Why One Startup CEO Is Excited About the White House’s New AI Czar Role
AI-Powered Smartphones Could Offset a Data Center Downturn
Best of 2024: The Medical Economics Tech Issue on AI

Share This Article